BlackRock, Inc.
- SEC CIK
- 0002012383
- Latest filing
- Aug 7, 2026
ENVB holding history
Enveric Biosciences, Inc. in every 13F filed by BlackRock, Inc., including the quarters it was sold out or no filing was made. Changes compare share counts with the previous calendar quarter.
ENVB overviewAll 13F holders of ENVBFull Q2 2026 holdings
- Shares (Q2 2026)
- 51
- Value
- $70
- % of portfolio
- <0.1%
- Quarters held
- 8
- Since Q3 2024
| Quarter | Shares | Value | % of portfolio | Share change | Action | All holders |
|---|---|---|---|---|---|---|
| Q2 2026 | 51 | $70 | <0.1% | 00.0% | Unchanged | Holders |
| Q1 2026 | 51 | $99 | <0.1% | 00.0% | Unchanged | Holders |
| Q4 2025 | 51 | $185 | <0.1% | −550−91.5% | Reduced | Holders |
| Q3 2025 | 601 | $384 | <0.1% | 00.0% | Unchanged | Holders |
| Q2 2025 | 601 | $727 | <0.1% | 00.0% | Unchanged | Holders |
| Q1 2025 | 601 | $835 | <0.1% | −8,409−93.3% | Reduced | Holders |
| Q4 2024 | 9,010 | $3.23K | <0.1% | 00.0% | Unchanged | Holders |
| Q3 2024 | 9,010 | $4.27K | <0.1% | – | No prior filing | Holders |